Cadrenal Therapeutics, Inc. Quarterly Assets in USD from Q4 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Cadrenal Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2022 to Q3 2024.
Cadrenal Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $4.68M, a 49.7% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$4.68M	-$4.63M	-49.7%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$5.46M	+$1.9M	+53.3%	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$7.05M	+$2.57M	+57.3%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$8.52M	+$7.74M	+995%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$9.31M			Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$3.56M			Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$4.48M			Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$778K			Dec 31, 2022	10-K	2024-03-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.